Eli Lily will undertake the acquisition of Curevo, Limmatech and Vaccine Co.
Photo Source: Freepik
Eli Lilly is set to acquire three vaccine developers for the sum of $4 billion, according to a report from the Wall Street Journal on Tuesday, The US-based pharmaceutical firm will undertake the acquisition of Curevo, Limmatech and Vaccine Co, in order to consolidate its vaccine and infectious disease treatment portfolio.
(This is a developing story.)
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
